Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
Holcomb K, Vucetic Z, Miller MC, Knapp RC.
Am J Obstet Gynecol. 2011 Oct;205(4):358.e1-6. Epub 2011 May 14.
Related citations
A regressive Meigs syndrome after definitive adnexal torsion.
Rousset P, Chaillot PF, Bats AS, Le Frère Belda MA, Buy JN.
Am J Obstet Gynecol. 2011 Oct;205(4):e4-5. Epub 2011 Apr 16.
Silent existence: a retroperitoneal tumor had an unexpected origin.
Liang TJ, Liu SI, Chen IS.
Am J Obstet Gynecol. 2011 Aug;205(2):160.e1-2. Epub 2011 Jun 21. No abstract available.
Natural history and outcome of mucinous carcinoma of the ovary.
Schiavone MB, Herzog TJ, Lewin SN, Deutsch I, Sun X, Burke WM, Wright JD.
Am J Obstet Gynecol. 2011 Nov;205(5):480.e1-8. Epub 2011 Jun 21.
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA.
Am J Obstet Gynecol. 2011 Jun;204(6):466-78. Review.
Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.
Li LC, Jayaram S, Ganesh L, Qian L, Rotmensch J, Maker AV, Prabhakar BS.
Am J Obstet Gynecol. 2011 Oct;205(4):362.e12-25. Epub 2011 May 27.
Evaluation and management of adnexal mass in pregnancy.
Hoover K, Jenkins TR.
Am J Obstet Gynecol. 2011 Aug;205(2):97-102. Epub 2011 May 14. Review.
Anti-N-methyl-D-aspartate receptor encephalitis complicating ovarian teratomas: a case report.
Naoura I, Didelot A, Walker F, Luton D, Koskas M.
Am J Obstet Gynecol. 2011 Oct;205(4):e6-8. Epub 2011 May 10.
Fertility preserving options in patients with gynecologic malignancies.
Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE.
Am J Obstet Gynecol. 2011 Aug;205(2):103-10. Epub 2011 Mar 16. Review.
Clinical characteristics of ovarian teratoma: age-focused retrospective analysis of 580 cases.
Kim MJ, Kim NY, Lee DY, Yoon BK, Choi D.
Am J Obstet Gynecol. 2011 Jul;205(1):32.e1-4. Epub 2011 Feb 23.
Prognostic value of lymph node involvement in ovarian serous borderline tumors.
Lesieur B, Kane A, Duvillard P, Gouy S, Pautier P, Lhommé C, Morice P, Uzan C.
Am J Obstet Gynecol. 2011 May;204(5):438.e1-7. Epub 2011 Feb 24.
Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer.
Barrena Medel NI, Herzog TJ, Deutsch I, Burke WM, Sun X, Lewin SN, Wright JD.
Am J Obstet Gynecol. 2011 Mar;204(3):248.e1-7. Epub 2011 Jan 17.
Images in gynecology. A different twist: the patient had an ovarian mass with torsion. Or did she?
Kim TH, Lee HH, Chung SH.
Am J Obstet Gynecol. 2010 Dec;203(6):599.e1-2. No abstract available.
Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, Garg G, Morris R, Ali-Fehmi R.
Am J Obstet Gynecol. 2011 Jan;204(1):63.e1-7. Epub 2010 Nov 11.
Inadvertent rupture of benign cystic teratoma does not impair future fertility.
Pansky M, Shade D, Moskovitch M, Halperin R, Ben-Ami I, Smorgick N.
Am J Obstet Gynecol. 2010 Nov;203(5):442.e1-4. Epub 2010 Aug 24.
Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review.
Medeiros LR, Freitas LB, Rosa DD, Silva FR, Silva LS, Birtencourt LT, Edelweiss MI, Rosa MI.
Am J Obstet Gynecol. 2011 Jan;204(1):67.e1-10. Epub 2010 Nov 3. Review.
Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study.
Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH.
Am J Obstet Gynecol. 2011 Feb;204(2):167.e1-5. Epub 2010 Nov 3.
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.
Shih IeM, Chen L, Wang CC, Gu J, Davidson B, Cope L, Kurman RJ, Xuan J, Wang TL.
Am J Obstet Gynecol. 2010 Dec;203(6):584.e1-22. Epub 2010 Oct 20.
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
Richter CE, Cocco E, Bellone S, Silasi DA, Rüttinger D, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
Am J Obstet Gynecol. 2010 Dec;203(6):582.e1-7. Epub 2010 Sep 25.
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
Greene MH, Mai PL, Schwartz PE.
Am J Obstet Gynecol. 2011 Jan;204(1):19.e1-6. Epub 2010 Jul 8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on